| HOME >> BIOLOGY >> TECHNOLOGY |
-related charges (c) $44
Income tax benefit (d) (12)
Restructuring-related charges, net of tax $32
Amortization expense:
Amortization expense $143 $155
Income tax benefit (d) (34) (33)
Amortization expense, net of tax $109 $122
(a) Recorded expenses of $9 million to selling, general and administrative
expenses, $2 million to cost of products sold, and $1 million to
research and development expenses.
(b) Recorded to other, net.
(c) Recorded $29 million to restructuring charges, $9 million to selling,
general and administrative expenses, $4 million to cost of products
sold, and $2 million to research and development expenses.
(d) Amounts are tax effected at the Company's effective tax rate, unless
the amount is a significant unusual or infrequently occurring item in
accordance with FASB Interpretation No. 18, "Accounting for Income
Taxes in Interim Periods."
BOSTON SCIENTIFIC CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
March 31, December 31,
In millions 2008 2007
Assets
Current assets:
Cash and cash equivalents $1,739 $1,452
Trade accounts receivable, net 1,496 1,502
Inventories 781 725
Deferred income taxes 873 679
Assets held for sale 1,099
Other current assets 352
'/>"/>
| SOURCE Boston Scientific Corporation Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Boston Scientific Amends Credit Facility and Prepays $1 Billion on Loan
4. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
5. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
6. Boston Scientific Announces Election of Ray Elliott to Its Board of Directors
7. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
8. Boston Scientific Releases Remote Monitoring Data from its Wireless LATITUDE(R) Patient Management System
9. Genzyme Begins Major Expansion of Boston Manufacturing Facility
10. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
11. Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |